Core B: Laboratory Testing CoreThe Testing Laboratory Core B has the goal to serve every project in the Program. It will provide an array ofassays assessing fibrinolysis, coagulation, anticoagulant activities, and plasma lipid profiles. The Core willalso provide assays of inflammatory cytokines, and adipokines as well as with established kits for mouseproteins associated with thrombosis, atherosclerosis and obesity. The specific assays that are available foreach of the projects are indicated below. Core B will also coordinate the high through-put screening of smallmolecules by the Center for Chemical Genomics.Project 1: Core B will perform analysis of plasma PAI-1 levels for both active and inactive PAI-1 and ofplasminogen activator antigen and activity levels. In addition, plasma lipid profiles will be routinelydetermined and immunoassays of various inflammatory cytokines as well as adipokines will be measured ina mutiplex format using the Luminex Technology. High through-put screening of small molecule compoundlibraries for the development of novel PAI-1 inactivating agents will also be performed through the Center forChemical Genomics.Project 2: Core B will perform analysis of plasma PAI-1 levels for both active and inactive PAI-1 and ofplasminogen activator antigen and activity levels. Murine plasmas will also be analyzed for increased risk forthrombosis by determining the levels of plasma coagulation, and anticoagulant proteins in various strains ofmice at baseline, and after venous thrombosis with or without hypercholesterolemia. D-dimer levels will alsobe measured. Procoagulant microparticles will also be measured as well as immunoassays of variousinflammatory cytokines.Project 3: Core B will assist the investigators off Project 3 by assessing platelet function including bleedingtimes and platelet aggregation in mice. Fibrinolytic parameters will be determined including PAI-1 andplasminogen activator levels. Immunoassays of various inflammatory cytokines will also be measured in amutiplex format using the Luminex Technology.Project 4: Core B will assist the investigators of Project 4 by developing novel, assays forcoagulation/fibrinolysis and platelet function in Zebrafish. These assays will include immunoassays andfunctional assays such as clotting times as well as factor assays.The overall goals of the Testing Laboratory Core B are to enhance the success of each individual project byproviding rigorous, standardized assays and to ensure that the combined Program is stronger than each ofits individual parts.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
1P01HL089407-01A1
Application #
7485908
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2008-04-28
Project End
2013-03-31
Budget Start
2008-04-28
Budget End
2009-03-31
Support Year
1
Fiscal Year
2008
Total Cost
$268,359
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Obi, Andrea T; Andraska, Elizabeth; Kanthi, Yogendra et al. (2017) Endotoxaemia-augmented murine venous thrombosis is dependent on TLR-4 and ICAM-1, and potentiated by neutropenia. Thromb Haemost 117:339-348
Obi, Andrea T; Andraska, Elizabeth; Kanthi, Yogendra et al. (2016) Gram-Negative Pneumonia Alters Large-Vein Cell-Adhesion Molecule Profile and Potentiates Experimental Stasis Venous Thrombosis. J Vasc Res 53:186-195
Wu, Jianbo; Strawn, Tammy L; Luo, Mao et al. (2015) Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-?V?3 integrin cross talk. Arterioscler Thromb Vasc Biol 35:111-20
Obi, A T; Diaz, J A; Ballard-Lipka, N L et al. (2014) Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism. J Thromb Haemost 12:1353-63
Obi, Andrea T; Diaz, Jose A; Ballard-Lipka, Nicole L et al. (2014) Low-molecular-weight heparin modulates vein wall fibrotic response in a plasminogen activator inhibitor 1-dependent manner. J Vasc Surg Venous Lymphat Disord 2:441-450.e1
Li, Shih-Hon; Reinke, Ashley A; Sanders, Karen L et al. (2013) Mechanistic characterization and crystal structure of a small molecule inactivator bound to plasminogen activator inhibitor-1. Proc Natl Acad Sci U S A 110:E4941-9
Diaz, Jose A; Alvarado, Christine M; Wrobleski, Shirley K et al. (2013) The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse. Thromb Haemost 109:1158-69
Patterson, K A; Zhang, X; Wrobleski, S K et al. (2013) Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects. Thromb Res 131:268-76
Shuster, Katherine A; Wrobleski, Shirley K; Hawley, Angela E et al. (2013) Prothrombotic effects of thrombolytic therapy in a rat (Rattus norvegicus) model of venous thrombolysis. Comp Med 63:244-51
Osterholzer, John J; Christensen, Paul J; Lama, Vibha et al. (2012) PAI-1 promotes the accumulation of exudate macrophages and worsens pulmonary fibrosis following type II alveolar epithelial cell injury. J Pathol 228:170-80

Showing the most recent 10 out of 37 publications